← Leaderboards
Lynn Morris
Univ Of Med/Dent Of Nj-Nj Medical School
$5,328,268
Attributed
$5,984,113
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $887.9K · FY2010–21$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,984,113 · 5
By mechanism
U01$2,113,762 · 2
R01$2,030,538 · 1
P01$1,839,813 · 2
Top collaborators
- Peter D Kwong5 shared
- John R Mascola5 shared
- Penny Moore5 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesCohortAntigensHiv VaccineHiv-1AntibodiesSpecificityInfectionSamplingNeutralizing AntibodyEvolutionDesignStructureMonoclonal AntibodiesVirusParticipantVariantViralInterestEpitopesResponseVaccinesSouth AfricaImmunoglobulin Genes
Grant awards (20)
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection$246,383
U01 · FY2021 · AI · contact PI
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection$246,466
U01 · FY2020 · AI · contact PI
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection$247,623
U01 · FY2019 · AI · contact PI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2019 · AI
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection$248,838
U01 · FY2018 · AI · contact PI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2018 · AI
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection$249,992
U01 · FY2017 · AI · contact PI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2017 · AI
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec$496,476
R01 · FY2016 · AI · contact PI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2016 · AI
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec$511,272
R01 · FY2015 · AI · contact PI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2015 · AI
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec$519,608
R01 · FY2014 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$368,266
P01 · FY2014 · AI · contact PI
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec$503,182
R01 · FY2013 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$328,920
P01 · FY2013 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$29,811
P01 · FY2013 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$374,518
P01 · FY2012 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$366,172
P01 · FY2011 · AI · contact PI
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs$372,126
P01 · FY2010 · AI · contact PI